Literature DB >> 7722223

[Keratoconus and familial topographic corneal anomalies].

D Salabert1, B Cochener, F Mage, J Colin.   

Abstract

PURPOSE: Computer-assisted corneal topography, allows the detection of early abnormalities, including abortive or subclinical forms of keratoconus. So, it is possible to identify affected individuals with variable degrees, in family members of patients with keratoconus, to draw pedigrees, and to specify the mode of inheritance.
METHODS: Computer-assisted digital videophotokeratoscope was used to map the corneas of 106 family members of 30 patients with keratoconus.
RESULTS: Abnormalities observed included the inferior cornea markedly steeper than the superior cornea (I-S - 0.86 +/- 0.44 D) and a marked difference between the central corneal powers of the two eyes (delta PC = 0.72 +/- 0.22 D). However, there was no statistical difference with normal individuals for central corneal power.
CONCLUSION: Pedigree analysis in these families suggests, in 50% of them, an autosomal dominant mode of inheritance. However, it is impossible to conclude for the other families, because of an insufficient number of cases.

Entities:  

Mesh:

Year:  1994        PMID: 7722223

Source DB:  PubMed          Journal:  J Fr Ophtalmol        ISSN: 0181-5512            Impact factor:   0.818


  3 in total

1.  Corneal topographic changes in healthy siblings of patients with keratoconus.

Authors:  Mohammad Reza Besharati; Mohammad Reza Shoja; Masoud Reza Manaviat; Maryam Kheirandish; Maasome Zare Rad
Journal:  Int J Ophthalmol       Date:  2010-03-18       Impact factor: 1.779

2.  Optical coherence tomography combined with videokeratography to differentiate mild keratoconus subtypes.

Authors:  Yaron S Rabinowitz; Xiaohui Li; Ana Laura Caiado Canedo; Renato Ambrósio; Yelena Bykhovskaya
Journal:  J Refract Surg       Date:  2014-02       Impact factor: 3.573

3.  Genetic association of COL5A1 variants in keratoconus patients suggests a complex connection between corneal thinning and keratoconus.

Authors:  Xiaohui Li; Yelena Bykhovskaya; Ana Laura Caiado Canedo; Talin Haritunians; David Siscovick; Anthony J Aldave; Loretta Szczotka-Flynn; Sudha K Iyengar; Jerome I Rotter; Kent D Taylor; Yaron S Rabinowitz
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-04-12       Impact factor: 4.799

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.